Company expects to have sufficient cash to fund planned operations beyond the FDA PDUFA goal date and anticipated fourth ...
As part of our broader growth strategy, IR-MED is actively working toward uplisting to the Nasdaq Stock Exchange, a move that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback